|

Spedox-6 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • University of California, Irvine1

Indications

  • KRAS Mutation-Related Tumors1
  • Soft Tissue Sarcoma1
  • Triple Negative Breast Cancer1
  • Ovarian Cancer1
  • Cervical Cancer1

Orange, California1 trial

Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies

Chao Family Comprehensive Cancer Center University of California, Irvine

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.